Detail akcie Sernova Rg online

Business Summary: Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Financial Summary: BRIEF: For the six months ended 30 April 2025, Sernova Biotherapeutics Inc revenues was not reported. Net loss decreased 52% to C$9.5M. Lower net loss reflects Research and Dev - Balancing decrease of 70% to C$3.6M (expense), Consulting and professional fees decrease of 67% to C$593K (expense), Share based compensation in R&D decrease of 88% to C$130K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.06 to -C$0.03.